Lancet Respir Med, 2213-2600

Journal

1 - 10 out of 11Page size: 10

Publications

  1. 2020
  2. Published

    Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial

    Gary Middleton, Kristian Brock & Lucinda Billingham, Sep 2020, In: The Lancet Respiratory Medicine. 8, 9, p. 895-904 10 p.

    Research output: Contribution to journal › Article › peer-review

  3. 2019
  4. Published

    Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial

    Sue Mallett & 19 others, , Laura Quinn, Jun 2019, In: The Lancet Respiratory Medicine. 7, 6, p. 523-532 10 p.

    Research output: Contribution to journal › Article › peer-review

  5. 2018
  6. Published

    Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.

    & 99 others, , Michael Newnham, 5 Dec 2018, In: Lancet Respir Med. 7, 3, p. 227-238 12 p.

    Research output: Contribution to journal › Article › peer-review

  7. Published

    COPD exacerbations: transforming outcomes through research

    Elizabeth Sapey, 1 Mar 2018, In: The Lancet Respiratory Medicine. 6, 3, p. 172-174 3 p.

    Research output: Contribution to journal › Comment/debate › peer-review

  8. 2016
  9. Published

    Targeted case finding for chronic obstructive pulmonary disease versus routine practice in primary care (TargetCOPD): a cluster-randomised controlled trial

    Rachel Jordan, Peymane Adab, Alice Sitch, Deirdre Blissett, Sue Jowett, Richard Riley, Martin Miller, Alice Turner, Kate Jolly, Shamil Haroon, Sheila Greenfield, Amanda Daley, KK Cheng & David Fitzmaurice, Sep 2016, In: The Lancet Respiratory Medicine. 4, 9, p. 720-30 11 p.

    Research output: Contribution to journal › Article › peer-review

  10. 2015
  11. Published

    Reducing the health effect of particles from agriculture

    Roy Harrison, Nov 2015, In: The Lancet Respiratory Medicine. 3, 11, p. 831-832

    Research output: Contribution to journal › Article › peer-review

  12. Published

    A pooled analysis of 15,632 COPD patients comparing the GOLD 2007 and 2011 staging systems for COPD focused on mortality

    Alice Turner & 7 others, , Jun 2015, In: The Lancet Respiratory Medicine. 3, 6, p. 443-450 7 p.

    Research output: Contribution to journal › Article › peer-review

  13. Published

    Identification of children at risk of influenza-related complications in primary and ambulatory care: a systematic review and meta-analysis

    Sue Mallett, Feb 2015, In: The Lancet Respiratory Medicine. 3, 2, p. 139-49 11 p.

    Research output: Contribution to journal › Article › peer-review

  14. Published

    Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study

    Julian Bion & 19 others, , Jan 2015, In: The Lancet Respiratory Medicine. 3, 1, p. 53-60 8 p.

    Research output: Contribution to journal › Article › peer-review

  15. 2014
  16. Published

    Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data

    & 31 others, , Dhruv Parekh & Fang Gao Smith, May 2014, In: The Lancet Respiratory Medicine. 2, 5, p. 395-404 10 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 Next